
The Los Angeles County Board of Supervisors yesterday unanimously approved a motion to proclaim May 2025 as Brain Tumor Awareness Month. Introduced by Board Chair Kathryn Barger and co-authored by Supervisor Holly J. Mitchell, the declaration aims to raise awareness, honor the resilience of individuals living with brain tumors, and recognize the vital work of healthcare professionals and researchers in the fight against brain cancer.
“Brain tumors affect thousands of lives across our County and beyond, often with devastating physical and emotional impacts,” said Supervisor Kathryn Barger. “By declaring May as Brain Tumor Awareness Month, we’re standing in solidarity with patients, survivors, families, and medical professionals who courageously confront this disease every day. I’m proud to recognize the USC Brain Tumor Center for its groundbreaking work and commitment to care.”
The proclamation aligns with a national movement recognizing May as Brain Tumor Awareness Month, also known as #GrayMay. According to the National Cancer Institute, Los Angeles County diagnoses and treats more brain tumors than any other County in California. The County is also home to the USC Brain Tumor Center, which provides comprehensive, personalized care using state-of-the-art diagnostics and treatments.
“I’m proud to join Chair Barger in uplifting the importance of recognizing Brain Tumor Awareness Month in Los Angeles County and the lifesaving work of the USC Brain Tumor Center,” said Supervisor Holly J. Mitchell. “This May, we reaffirm our commitment to equitable access to early detection, quality care, and innovative treatments.”
“Recognizing May 2025 as Brain Tumor Awareness Month is essential to advancing brain tumor care and research, both of which are critical to improving patient outcomes and driving progress toward cures,” said Gabriel Zada, MD, co-director of the USC Brain Tumor Center. “At the USC Brain Tumor Center, we are proud to have helped champion this important recognition from the County of Los Angeles. Our team remains deeply committed to providing patients and their families with access to leading-edge surgical technology, innovative clinical trials, compassionate multidisciplinary care and a responsive support system from diagnosis through recovery.”
This proclamation aims to amplify the voices of those affected while supporting the ongoing mission to cure and eradicate brain tumors.